Wall Street analyst estimates for CONMED Corporation (CNMD): consensus price target, buy/hold/sell recommendations and forecasts for revenue, EPS and EBITDA for the upcoming fiscal years.
CONMED Corporation functions as a medical technology enterprise, specializing in the global development, production, and distribution of surgical instruments and related apparatus for a variety of surgical procedures. Its comprehensive product portfolio includes specialized orthopedic surgical items, such as the TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-Knot All-Suture Anchors, and PopLok Knotless Suture Anchors.
Recent Earnings Surprises
| Date | EPS Actual | EPS Est. | vs Est. |
|---|---|---|---|
| 2026-10-28 | $1.00 | ||
| 2026-07-29 | $1.38 | $1.11 | +24.3% |
| 2026-04-29 | $0.89 | $0.82 | +8.5% |
| 2026-01-28 | $1.43 | $1.32 | +8.3% |
| 2025-11-05 | $1.08 | $1.05 | +2.9% |
| 2025-07-30 | $1.15 | $1.13 | +1.8% |
| 2025-04-30 | $0.95 | $0.81 | +17.3% |
| 2025-02-05 | $1.34 | $1.20 | +11.7% |
Valuation Ratios
| P/E Ratio | 25.01 |
| Price / Book | 1.27 |
| EV / EBITDA | 12.11 |
| Dividend Yield | 0.45% |
Income Statement (10y)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $763.5M | $796.4M | $859.6M | $955.1M | $862.5M | $1.01B | $1.05B | $1.24B | $1.31B | $1.37B |
| Cost of Revenue | $355.2M | $365.4M | $390.5M | $430.4M | $402.2M | $442.6M | $474.2M | $568.5M | $574.0M | $649.1M |
| Gross Profit | $408.3M | $431.0M | $469.1M | $524.7M | $460.3M | $568.0M | $571.2M | $676.2M | $733.0M | $725.4M |
| Research & Development | $32.3M | $32.3M | $42.2M | $45.5M | $40.5M | $43.6M | $47.2M | $52.6M | $54.4M | $55.9M |
| Selling, General & Admin | $338.4M | $351.8M | $355.6M | $400.1M | $373.8M | $414.8M | $454.0M | $503.0M | $478.3M | $528.4M |
| Operating Expenses | $370.7M | $384.1M | $397.8M | $445.6M | $414.3M | $458.3M | $501.2M | $555.6M | $532.7M | $584.2M |
| Operating Income | $37.7M | $46.9M | $71.3M | $79.1M | $46.0M | $109.7M | $70.1M | $120.6M | $200.3M | $141.1M |
| EBITDA | $90.0M | $105.5M | $133.1M | $146.2M | $118.3M | $179.3M | $7.8M | $192.5M | $272.2M | $154.5M |
| Interest Expense | $15.4M | $18.2M | $20.7M | $42.7M | $44.1M | $35.5M | $28.9M | $39.8M | $37.3M | $31.1M |
| Pre-tax Income | $19.4M | $28.7M | $50.7M | $31.2M | $1.6M | $73.1M | -$70.9M | $80.8M | $163.0M | $71.1M |
| Income Tax | $4.7M | -$26.8M | $9.8M | $2.6M | -$7.9M | $10.6M | $9.7M | $16.4M | $30.6M | $24.1M |
| Net Income | $14.7M | $55.5M | $40.9M | $28.6M | $9.5M | $62.5M | -$80.6M | $64.5M | $132.4M | $47.1M |
| EPS | $0.53 | $1.99 | $1.45 | $1.01 | $0.33 | $2.14 | $-2.68 | $2.10 | $4.29 | $1.52 |
| EPS (Diluted) | $0.52 | $1.97 | $1.41 | $0.97 | $0.32 | $1.94 | $-2.68 | $2.04 | $4.26 | $1.51 |
| Shares Outstanding (Diluted) | $28.0M | $28.2M | $28.9M | $29.5M | $29.5M | $32.2M | $30.0M | $31.5M | $31.1M | $31.1M |
Price
| Price | $47.33 |
| Market Cap | $1.4B |
| Exchange | NYSE |
| Country | US |
Related companies: AHCO · AZTA · ESTA · INMD · KMTS · NEOG · NTLA
Explore sector: Healthcare · Medical - Devices
More sections of CNMD: Overview · Financials · Valuation · Statistics · Technical · Ownership · News · Events
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Investment Academy — learn to analyze stocks